Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 377, Issue 9, Pages 829-838
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2017-06-07
DOI
10.1056/nejmoa1704795

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.